 ?您的位置：對照品 > 標準物質(zhì) > 標準樣品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：T004922 |
| 產(chǎn)品名稱：TAK-901-d3 |
| 產(chǎn)品CAS：1346603-28-8 |
| 規(guī)格含量：10mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細介紹 |
| 標準品編號: |
T004922 |
| 名稱: |
TAK-901-d3 |
| 別名: |
5-[3-(Ethylsulfonyl)phenyl]-3,8-dimethyl-N-(1-methyl-4-piperidinyl)-9H-pyrido[2,3-b]indole-7-carboxamide; |
| CAS號: |
1346603-28-8 |
| 參考CAS號: |
934541-31-8 unlabelled |
| 分子式: |
C??H??D?N?O?S |
| 分子量: |
507.66 |
| 類別: |
Standards; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
A labelled novel Aurora B kinase inhibitor with potential antineoplastic activity. It binds to and inhibits the activity of Aurora B, which may result in a decrease in the proliferation of tumor cells that overexpress Aurora B. Aurora B is a positive regulator of mitosis that functions in the attachment of the mitotic spindle to the centromere; the segregation of sister chromatids to each daughter cell; and the separation of daughter cells during cytokinesis. |
| 參考文獻 |
|
|
|
|
|
|
